Skip to main content

Paying for Treatment

What's new

You may have heard about Semglee and Rezvoglar, popular alternatives for Lantus insulin; these are “biosimilars.” But what is a biosimilar? How is it different from a generic drug? Find answers to these questions and some tips on how to discuss biosimilars with your healthcare provider. Continue Reading »

Civica, a nonprofit pharmaceutical company, announced plans to make generic insulin available for $30 per vial or $55 for five prefilled pens, regardless of insurance status. Continue Reading »

US pharmaceutical companies and insulin manufacturers react to proposed legislation that would cap insulin costs and prevent significant rises in the costs of prescription drugs. Continue Reading »

Lilly’s new basal insulin, Rezvoglar, may provide a cheaper alternative to Lantus. This marks the second approval of a biosimilar long-acting insulin. Continue Reading »

As we approach the new year, we want to remind you that if you've met your annual health insurance deductible or are close to meeting it, do not forget to order any diabetes supplies you need before your deductible resets on January 1 (in the US). Continue Reading »

For National Diabetes Awareness and Prevention Month, we asked members of the diaTribe community what access to care means to them. You can check out all of their responses here. Continue Reading »

A compromise reached among Congress and the Biden-Harris Administration would add a drug pricing plan to the Build Back Better Act that includes an insulin copay cap, a cap on annual out-of-pocket prescription drug costs, a rule allowing Medicare to negotiate prescription drug costs, and a drug inflation tax penalty. If passed, the proposed plan could improve access to diabetes care for millions. Continue Reading »

Ascensia Diabetes Care just launched a new Patient Assistance Program, which is now available in the US. The program aims to reduce out-of-pocket expenses for those who are starting or already using Senseonics’ Eversense 90-day implantable continuous glucose monitoring system. Continue Reading »

Pages